Retinal gene expression changes related to IOP exposure and axonal loss in DBA/2J mice

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 11, 2011, Pages 7807-7816

  Panagis, Lambros ^a   Zhao, Xiujun ^b   Ge, Yongchao ^b   Ren, Lizhen ^a   Mittag, Thomas W ^b   Danias, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; COMPLEMENT SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; INTRAOCULAR PRESSURE; MICROARRAY ANALYSIS; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTIC NERVE LESION; PRIORITY JOURNAL; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURAL BIOINFORMATICS; TONOMETER;

ANIMALS; AXONS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTRAOCULAR PRESSURE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; NERVE TISSUE PROTEINS; OCULAR HYPERTENSION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TONOMETRY, OCULAR;

EID: 80053623393     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-7063     Document Type: Article

References (43)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 120:714-720, 2002; discussion 829-30.
3. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol. 1983;118:1667-1677.
4. Mackenzie P, Cioffi G. How does lowering of intraocular pressure protect the optic nerve? Surv Ophthalmol. 2008;53(suppl 1): S39-S43.
5. Qu J, Wang D, Grosskreutz CL. Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res. 2010;91:48-53.
6. Howell GR, Libby RT, Jakobs TC, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol. 2007;179:1523-1537.
7. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Oph-thalmol Vis Sci. 1998;39:951-962.
8. Danias J, Lee KC, Zamora MF, et al. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthal-mol Vis Sci. 2003;44:5151-5162.
9. Dyka FM, May CA, Enz R. Metabotropic glutamate receptors are differentially regulated under elevated intraocular pressure. J Neu-rochem. 2004;90:190-202.
10. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter, M.L. Microar-ray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:977-985.
11. Du J, Tran T, Fu C, Sretavan DW. Upregulation of ephB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss. Invest Ophthalmol Vis Sci. 2007;48: 5567-5581.
12. Soto I, Oglesby E, Buckingham BP, et al. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci. 2008; 28:548-561.
13. Templeton JP, Nassr M, Vazquez-Chona FE, et al. Differential response of C57BL/6J mouse and DBA/2J mouse to optic nerve crush. BMC Neurosci. 2009;10:90.
14. Panagis L, Zhao X, Ge Y, Ren L, Mittag TW, Danias J. Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice. Invest Ophthalmol Vis Sci. 2010;51: 2024-2034.
15. Inman DM, Sappington RM, Horner PJ, Calkins DJ. Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:986-996.
16. Scholz M, Buder T, Seeber S, Adamek E, Becker CM, Lütjen-Drecoll E. Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice. Invest Ophthalmol Vis Sci. 2008;49:613-621.
17. Danias J, Kontiola AI, Filippopoulos T, Mittag T. Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci. 2003;44:1138-1141.
18. Nissirios N, Goldblum D, Rohrer K, Mittag T, Danias J. Noninvasive determination of intraocular pressure (IOP) in nonsedated mice of 5 different inbred strains. J Glaucoma. 2007;16:57-61.
19. Hubbell E, Liu WM, Mei R. Robust estimators for expression analysis. Bioinformatics. 2002;18:1585-1592.
20. Wu Z, Irizarry RA. Stochastic models inspired by hybridization theory for short oligonucleotide arrays. J Comput Biol. 2005;12: 882-893.
21. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformat-ics. Genome Biol. 2004;5:R80.
22. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article 3.
23. Hofman, P. DNA microarrays. Nephron Physiol. 2005;99:85-89.
24. Page GP, Zakharkin SO, Kim K, Mehta T, Chen L, Zhang K. Microarray analysis. Methods Mol Biol. 2007;404:409-430.
25. Wang DY, Ray A, Rodgers K, et al. Global gene expression changes in rat retinal ganglion cells in experimental glaucoma. Invest Oph-thalmol Vis Sci. 2010;51:4084-4095.
26. Guo Y, Cepurna WO, Dyck JA, Doser TA, Johnson EC, Morrison JC. Retinal cell responses to elevated intraocular pressure: a gene array comparison between the whole retina and retinal ganglion cell layer. Invest Ophthalmol Vis Sci. 2010;51:3003-3018.
27. Stasi K, Nagel D, Yang X, et al. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucoma-tous eyes. Invest Ophthalmol Vis Sci. 2006;47:1024-1029.
28. Wax MB, Tezel G, Yang J, et al. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J Neurosci. 2008; 28:12085-12096.
29. Bosco A, Inman DM, Steele MR, et al. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Invest Oph-thalmol Vis Sci. 2008;49:1437-1446.
30. Libby RT, Anderson MG, Pang IH, et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurode-generation. Vis Neurosci. 2005;22:637-648.
31. JAX Mice Product specifications. Strain name: DBA/2J, Stock no. 000671; Bar Harbor, ME: Jackson Laboratory; 2002.
32. Anderson MG, Smith RS, Hawes NL, et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet. 2001;30:81-85.
33. Anderson MG, Libby RT, Mao M, et al. Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol. 2006;4:20.
34. Feng L, Seymour AB, Jiang S, et al. The beta3A subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and night blindness. Hum Mol Genet. 1999;8:323-330.
35. Feng L, Rigatti BW, Novak EK, Gorin MB, Swank RT. Genomic structure of the mouse Ap3b1 gene in normal and pearl mice. Genomics. 2000;69:370-379
36. Holcombe DJ, Lengefeld N, Gole GA, Barnett NL. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model. Br J Ophthalmol. 2008;92:683-688.
37. Raymond ID, Pool AL, Vila A, Brecha NC. A Thy1-CFP DBA/2J mouse line with cyan fluorescent protein expression in retinal ganglion cells. Vis Neurosci. 2009;26:453-465.
38. Reichstein D, Ren L, Filippopoulos T, Mittag T, Danias J. Apoptotic retinal ganglion cell death in the DBA/2 mouse model of glaucoma. Exp Eye Res. 2007;84:13-21.
39. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006; 7:66.
40. Levkovitch-Verbin H, Quigley HA, et al. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2001;42:975-982.
41. Wetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component (C5); a 2-base pair gene deletion in a 5'-exon.JBiol Chem. 1990;265:2435-2440.
42. Ren L, Danias J. A role for complement in glaucoma? Adv Exp Med Biol. 2010;703:95-104.
43. Tezel G, Yang X, Luo C, et al. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci. 2010;51:5071-5082.